Latest filing published 03 Mar 2026 for AbbVie Inc., €4.7M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jeffrey Ryan Stewart is a declared insider of AbbVie Inc. (senior executive), with filings sourced from SEC (Form 4). Between 10 December 2021 and 27 February 2026, the trades on record add up to 25 filings.
On the market, this insider has only sold: 1 sale, €245k in total. Besides market trades, the filings include 20 share grants and 4 option exercises.
The latest filing, published on 3 March 2026, reports a share grant of €4.7M in AbbVie Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations